Sponsored Symposiums
You’re invited to the sponsored symposia at Breast Cancer Trials 47th Annual Scientific Meeting (ASM). You can register for selected symposia when completing your registration for the ASM. More information will be made available over the upcoming months.
Roche Sponsored Lunch Symposium
Roche will hold a Lunch Symposium on Wednesday, 29 July from 12:15 – 1:15 PM, titled ‘Decoding the Data: Evaluating the Role of Oral SERDs in HR+ Breast Cancer’. Click the button below to find out more.
Novartis Sponsored Dinner Symposium
Novartis will hold a Dinner Symposium on Wednesday, 29 July from 7:00 – 9:00 PM, titled ‘Optimising Adjuvant Management in HR+ HER2- Early Breast Cancer: Evolving Perspectives on Patient Selection’, following the Welcome Event. Click the button below to find out more.
Lilly Sponsored Breakfast Symposium
Lilly will hold a Breakfast Symposium on Thursday, 30 July from 7:30 – 8:45 AM, titled ‘Optimising Outcomes for HR+ HER2- EBC Patients Through Risk-Based Decision Making’. Click the button below to find out more.
AstraZeneca | Daiichi-Sankyo Sponsored Lunch Symposium
AstraZeneca | Daiichi-Sankyo will hold a Lunch Symposium on Thursday, 30 July from 12:30 – 1:30 PM on the topic ‘The Changing Paradigm for Treating HER2+ eBC‘. Click the button below to find out more.
GILEAD Sponsored Breakfast Symposium
Gilead will hold a Breakfast Symposium on Friday, 31 July from 8:00 – 9:15 AM on the topic ‘The Role of ADCs in Metastatic TNBC’. Click the button below to find out more.
Pfizer Sponsored Lunch Symposium
Pfizer will hold a Lunch Symposium on Friday, 31 July from 12:30 – 1:30 PM on the topic ‘Drivers, Resistance, Reinvention: The Next Chapter in ER+ Metastatic Breast Cancer’. Click the button below to find out more.